This episode currently has no reviews.
Submit ReviewIn this episode, Scott Becker is joined by Paige Twenter, Assistant Editor at Becker's Healthcare, to discuss the latest in healthcare pricing controversies, Mark Cuban's Cost Plus Drugs initiative, and ongoing drug shortages. Paige provides insights into the pricing debates surrounding GLP-1s, the expansion of affordable drug access, and the critical issue of oncology drug shortages affecting hospitals and patients nationwide.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review